Genenta Science S.p.A (GNTA) Retained Earnings (2020 - 2025)
Genenta Science S.p.A (GNTA) posted Retained Earnings of -$72.9 million for Q4 2025, down 7.5% sequentially from -$67.8 million in Q2 2025, and down 21.65% YoY from -$93.0 million in Q4 2024.
Genenta Science S.p.A (GNTA) Retained Earnings (2020 - 2025) Analysis & Trends
Genenta Science S.p.A has reported Retained Earnings for 6 years, with the latest figure at -$72.9 million in Q4 2025.
- Quarterly Retained Earnings fell 21.65% year-over-year to -$72.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$72.9 million (down 21.65% YoY) and the FY2025 annual result came in at -$72.9 million, down 21.65% from the prior year.
- Retained Earnings declined to -$72.9 million in Q4 2025 per GNTA's latest filing, from -$67.8 million in the prior quarter.
- Over five years, Retained Earnings peaked at -$30.9 million in Q4 2021 and troughed at -$72.9 million in Q4 2025.
- A 5-year average of -$50.1 million and a median of -$50.7 million in 2023 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2021 and 2022: Retained Earnings slumped 170.82% in 2021, then declined 17.06% in 2022.
- Over 5 years, Retained Earnings stood at -$30.9 million in 2021, then fell by 17.06% to -$36.2 million in 2022, then tumbled by 40.18% to -$50.7 million in 2023, then decreased by 18.09% to -$59.9 million in 2024, then slipped by 21.65% to -$72.9 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered -$72.9 million, -$67.8 million, and -$59.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.23 Bn | 132.38 Bn | 2.84 Bn | 15.69 Bn |
| 2 | Regeneron Pharmaceuticals | 86.97 Bn | 78.97 Bn | 3.93 Bn | 37.62 Bn |
| 3 | Argenx Se | 65.29 Bn | 60.11 Bn | 1.37 Bn | 558.00 Mn |
| 4 | Moderna | 59.88 Bn | 54.74 Bn | 52.00 Mn | 5.10 Bn |
| 5 | BeOne Medicines | 42.20 Bn | 37.11 Bn | 1.53 Bn | 13.05 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn | -6.33 Bn |
| 7 | BioNTech SE | 28.69 Bn | 10.30 Bn | 668.28 Mn | 20.91 Bn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 6.57 Bn |
| 9 | Royalty Pharma | 27.16 Bn | 26.33 Bn | - | 4.38 Bn |
| 10 | Genenta Science S.p.A | 25.03 Mn | -34.07 Mn | - | -72.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -72.87 Mn |
| Jun 30, 2025 | -67.78 Mn |
| Dec 31, 2024 | -59.90 Mn |
| Jun 30, 2024 | -55.12 Mn |
| Dec 31, 2023 | -50.72 Mn |
| Jun 30, 2023 | -45.97 Mn |
| Dec 31, 2022 | -36.18 Mn |
| Jun 30, 2022 | -31.09 Mn |
| Dec 31, 2021 | -30.91 Mn |
| Dec 31, 2020 | 43.64 Mn |